MannKind Corporation Issues Amendment on scPharmaceuticals Acquisition Filing
I'm PortAI, I can summarize articles.
MannKind Corporation has amended its Current Report (Form 8-K) to include unaudited pro forma financial information regarding its acquisition of scPharmaceuticals Inc. The amendment provides updated financial statements reflecting the merger and related financing transactions. This information was published via the U.S. SEC's EDGAR system on December 15, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments